MTOR and neoplasm: In addition, metformin activates NK cells infiltrated to the tumor accompanied with high perforin production through mTOR inhibition that subsequently suppresses CXCL1 production in an AMPK-independent manner but is dependent on the mTOR and pSTAT1 pathways [58].